Prevalence of current tobacco use in Czechia
Czechia: Prevalence of current tobacco use was 28.4% in 2024. ▼ Falling
Prevalence of current tobacco use in Czechia, 2000–2024
Source: Global Health Observatory Data Repository, World Health Organization (WHO). Measured in % of adults.
Analysis
In 2024, prevalence of current tobacco use in Czechia stood at 28.4%. That is the lowest value across all 9 years on record.
Compared with earlier readings it is down 0.4% on the previous year and down 7.2% over ten years.
Over the whole period, prevalence of current tobacco use in Czechia peaked at 34.7% in 2000 and was at its lowest, 28.4%, in 2024.
That places Czechia 37th out of 166 countries with data for 2024, putting it in the top quarter.
Prevalence of current tobacco use in Czechia, year by year
| Year | % of adults | Change |
|---|---|---|
| 2000 | 34.7% | — |
| 2005 | 33.3% | -4.0% |
| 2007 | 32.7% | -1.8% |
| 2010 | 31.9% | -2.4% |
| 2015 | 30.6% | -4.1% |
| 2020 | 29.3% | -4.2% |
| 2022 | 28.8% | -1.7% |
| 2023 | 28.5% | -1.0% |
| 2024 | 28.4% | -0.4% |
Czechia compared with similar countries
- Czechia's 28.4% is above the median for high income countries, which is 21.2%, 1.3× the median. (57 countries reporting)
- Czechia's 28.4% is above the median for Europe & Central Asia, which is 26.1%, 1.1× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 33.6% | 32.7% | 34.7% | 3 |
| 2010s | 31.2% | 30.6% | 31.9% | 2 |
| 2020s | 28.8% | 28.4% | 29.3% | 4 |
Countries ranked near Czechia
More health data for Czechia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.7726 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,169 deaths per 1,000 people (2090)
- Number of infants who die before age 1 34 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.76 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0222 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.46 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is prevalence of current tobacco use in Czechia?
- Prevalence of current tobacco use in Czechia was 28.4% in 2024, according to Global Health Observatory Data Repository, World Health Organization (WHO).
- What is the highest prevalence of current tobacco use recorded in Czechia?
- The highest recorded value was 34.7% in 2000.
- What is the lowest prevalence of current tobacco use recorded in Czechia?
- The lowest recorded value was 28.4% in 2024.
- How does Czechia rank for prevalence of current tobacco use?
- Czechia ranks 37th out of 166 countries with data for 2024.
- Is prevalence of current tobacco use rising or falling in Czechia?
- Over the last ten years it is down 7.2%. The long-run trend across the full record is falling.
- Where does this Czechia data come from?
- The figures come from Global Health Observatory Data Repository, World Health Organization (WHO), published as part of Prevalence of current tobacco use (% of adults). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.